We are live on ! Find out more
APVO icon

Aptevo Therapeutics
APVO

1 hedge funds and large institutions have $65.5M invested in Aptevo Therapeutics in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

27% less capital invested

Capital invested by funds: $89.7M → $65.5M (-$24.2M)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
-$1.53M
2
Two Sigma Investments
Two Sigma Investments
New York
-$1.21M
3
SCM
Stonepine Capital Management
Oregon
-$1.18M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$928K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$674K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tang Capital Management
California
$39.5M – – –
RI
2
RTW Investments
New York
$6.31M – – –
KCM
3
Kennedy Capital Management
Missouri
$4.22M – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$3.59M – – –
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$3.12M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$3.02M – – –
BlackRock
7
BlackRock
New York
$1.22M – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$872K – – –
AFM
9
Anson Funds Management
Texas
$798K – – –
Northern Trust
10
Northern Trust
Illinois
$508K – – –
Balyasny Asset Management
11
Balyasny Asset Management
Illinois
$404K – – –
QI
12
QS Investors
New York
$352K – – –
BFM
13
Boothbay Fund Management
New York
$344K – – –
Verition Fund Management
14
Verition Fund Management
Connecticut
$336K – – –
DTL
15
Dynamic Technology Lab
Singapore
$315K – – –
State Street
16
State Street
Massachusetts
$246K – – –
Morgan Stanley
17
Morgan Stanley
New York
$187K – – –
JC
18
JBF Capital
Colorado
$88K – – –
UBS Group
19
UBS Group
Switzerland
$41K – – –
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$36K – – –
Wells Fargo
21
Wells Fargo
California
$35K – – –
Fifth Third Bancorp
22
Fifth Third Bancorp
Ohio
$7K – – –
IA
23
IFP Advisors
Florida
$5K – – –
PNC Financial Services Group
24
PNC Financial Services Group
Pennsylvania
$3K – – –
TC
25
Truvestments Capital
Florida
$3K – – –
1
2

APVO Hedge Fund Activity: Q2 2021 in Review

1 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Aptevo Therapeutics (APVO) for Q2 2021, worth a combined $65.5M — down 27% from $89.7M a quarter earlier.

Fund positioning in APVO was balanced in Q2 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Ghost Tree Capital, cutting an estimated $1.53M.

  • 1 institutional investor held Aptevo Therapeutics (APVO) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $65.5M of Aptevo Therapeutics stock for Q2 2021, down 27% quarter-over-quarter.
  • 0 funds opened new Aptevo Therapeutics positions in Q2 2021 and 0 closed out.
  • The largest Aptevo Therapeutics seller in Q2 2021 was Ghost Tree Capital, an estimated $1.53M sold.

Based on aggregated 13F filings for Q2 2021.